Header

UZH-Logo

Maintenance Infos

N-terminal pro-B-type natriuretic peptide ratio predicts mortality after transcatheter aortic valve replacement


Stähli, Barbara E; Gebhard, Cathérine; Saleh, Lanja; Falk, Volkmar; Landmesser, Ulf; Nietlispach, Fabian; Maisano, Francesco; Lüscher, Thomas F; Maier, Willibald; Binder, Ronald K (2015). N-terminal pro-B-type natriuretic peptide ratio predicts mortality after transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions, 85(7):1240-1247.

Abstract

Objectives: We studied the prognostic value of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP)-ratio, which is independent of individual cut-off levels, in predicting mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Background: Elevated levels of natriuretic peptides are associated with adverse outcomes across a wide spectrum of cardiovascular diseases. However, cut-off values differ according to age, gender, and body weight. Methods: 244 TAVR patients with pre-procedural NT-proBNP levels were analyzed, and the predictive value of NT-proBNP-ratio (measured NT-proBNP/maximal normal NT-proBNP values specific for age and gender) on all-cause-mortality was assessed in a multivariate model. Results: Median BNP-ratio was 4.2 [IQR 1.8-9.7]. All-cause mortality at 30 days was 3.4% in patients with less than median NT-proBNP-ratio, and 14.0% in patients with more than median NT-proBNP-ratio (p=0.02). All-cause mortality at 1 year was 8.5% in patients with less than median NT-proBNP-ratio, and 32.1% in those with more than median NT-proBNP-ratio (p=0.001). Cumulative survival declined with increasing quartiles of NT-proBNP-ratio (log rank p=0.001). All patients with a NT-proBNP-ratio below 1.5 survived at 1 year follow-up. In ROC analysis, NT-proBNP-ratio significantly predicted 30-day (AUC=0.72; p=0.002) and 1-year all-cause mortality (AUC=0.72; p<0.001). By multivariate Cox regression analysis, NT-proBNP-ratio, chronic obstructive pulmonary disease, and serum creatinine were the only independent predictors of all-cause mortality. Conclusions: Elevated NT-proBNP-ratio was associated with increased short- and long-term mortality after TAVR, and independently predicted all-cause mortality. NT-proBNP-ratio should be considered in the risk stratification of patients undergoing TAVR. This article is protected by copyright. All rights reserved.

Abstract

Objectives: We studied the prognostic value of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP)-ratio, which is independent of individual cut-off levels, in predicting mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Background: Elevated levels of natriuretic peptides are associated with adverse outcomes across a wide spectrum of cardiovascular diseases. However, cut-off values differ according to age, gender, and body weight. Methods: 244 TAVR patients with pre-procedural NT-proBNP levels were analyzed, and the predictive value of NT-proBNP-ratio (measured NT-proBNP/maximal normal NT-proBNP values specific for age and gender) on all-cause-mortality was assessed in a multivariate model. Results: Median BNP-ratio was 4.2 [IQR 1.8-9.7]. All-cause mortality at 30 days was 3.4% in patients with less than median NT-proBNP-ratio, and 14.0% in patients with more than median NT-proBNP-ratio (p=0.02). All-cause mortality at 1 year was 8.5% in patients with less than median NT-proBNP-ratio, and 32.1% in those with more than median NT-proBNP-ratio (p=0.001). Cumulative survival declined with increasing quartiles of NT-proBNP-ratio (log rank p=0.001). All patients with a NT-proBNP-ratio below 1.5 survived at 1 year follow-up. In ROC analysis, NT-proBNP-ratio significantly predicted 30-day (AUC=0.72; p=0.002) and 1-year all-cause mortality (AUC=0.72; p<0.001). By multivariate Cox regression analysis, NT-proBNP-ratio, chronic obstructive pulmonary disease, and serum creatinine were the only independent predictors of all-cause mortality. Conclusions: Elevated NT-proBNP-ratio was associated with increased short- and long-term mortality after TAVR, and independently predicted all-cause mortality. NT-proBNP-ratio should be considered in the risk stratification of patients undergoing TAVR. This article is protected by copyright. All rights reserved.

Statistics

Citations

Dimensions.ai Metrics
12 citations in Web of Science®
9 citations in Scopus®
6 citations in Microsoft Academic
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiovascular Surgery
04 Faculty of Medicine > University Hospital Zurich > Institute of Clinical Chemistry
04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
540 Chemistry
Uncontrolled Keywords:Radiology Nuclear Medicine and imaging, Cardiology and Cardiovascular Medicine, General Medicine
Language:English
Date:2015
Deposited On:14 Jan 2015 08:27
Last Modified:18 Aug 2018 18:57
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1522-1946
OA Status:Closed
Publisher DOI:https://doi.org/10.1002/ccd.25788
PubMed ID:25511571

Download

Full text not available from this repository.
View at publisher

Get full-text in a library